Successful therapeutic approach in a patient with elephantiasic pretibial myxedema,
AUTOR(ES)
Ferreira, Marina; Zacaron, Luciana Helena; Valle, Annair Freitas do; Gamonal, Aloisio Carlos Couri
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2020-08
RESUMO
Abstract Localized pretibial myxedema is a dermopathy whose treatment is a challenge in dermatology, occurring in 0.5-4% of patients with Graves’ disease. This autoimmune thyroid condition stimulates the production of hyaluronic acid and glycosaminoglycans that are deposited particularly in the pretibial region. Clinically, it presents as a localized, circumscribed, and non-depressible infiltrate in plaques. Several treatment modalities have been proposed, and their results vary, with worse response observed in severe cases. This report presents the case of a patient with elephantiasic pretibial myxedema who was subjected to intralesional corticosteroid applications, resulting in an excellent and encouraging therapeutic response that was maintained.
Documentos Relacionados
- Pre-tibial myxedema: treatment with intralesional corticosteroid
- MUCOPOLYSACCHARIDE CONTENT OF SKIN IN PATIENTS WITH PRETIBIAL MYXEDEMA*†
- Successful therapeutic intervention in a schizophrenic patient with blepharospasm.
- STUDIES IN BLOOD VOLUME: I. The Blood Volume in Myxedema, with A Comparison of Plasma Volume Changes in Myxedema and Cardiac Edema 12
- RADIOTHYROXINE TURNOVER STUDIES IN MYXEDEMA, THYROTOXICOSIS, AND HYPERMETABOLISM WITHOUT ENDOCRINE DISEASE